4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole → 4-[2-(1H-indazol-4-yl)-6-(3-methoxyprop-1-enyl)thieno[3,2-d]pyrimidin-4-yl]morpholine
Reaction equation
[CH3:22][C:23]1([CH3:24])[C:25]([CH3:26])([CH3:27])[O:28][B:29]([c:30]2[c:31]3[cH:32][n:33][nH:34][c:35]3[cH:36][cH:37][cH:38]2)[O:39]1.[Cl:1][c:2]1[n:3][c:4]([N:16]2[CH2:17][CH2:18][O:19][CH2:20][CH2:21]2)[c:5]2[c:6]([n:7]1)[cH:8][c:9]([CH:11]=[CH:12][CH2:13][O:14][CH3:15])[s:10]2>>[c:2]1(-[c:30]2[c:31]3[cH:32][n:33][nH:34][c:35]3[cH:36][cH:37][cH:38]2)[n:3][c:4]([N:16]2[CH2:17][CH2:18][O:19][CH2:20][CH2:21]2)[c:5]2[c:6]([n:7]1)[cH:8][c:9]([CH:11]=[CH:12][CH2:13][O:14][CH3:15])[s:10]2Participants
3
Sources & evidence
- ORD record
- ord-d9a32a395d9848ed92677e63a27f3582
- Source dataset
- Training data from https://doi.org/10.1039/C8SC04228D (10/10)
Reaction notes
Loading…